As pharmaceutical companies increasingly rely on artificial intelligence (AI) to optimise trial processes, the potential for AI models to drift over time poses significant risks to trial integrity ...
Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, and Medicines for Europe – which represents the generic pharma industry – ...
According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated Disclosure UK system operated by the Association of the British ...